Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and guanosine triphosphate

angiotensin ii, des-phe(8)- has been researched along with guanosine triphosphate in 1 studies

Compound Research Comparison

Studies
(angiotensin ii, des-phe(8)-)
Trials
(angiotensin ii, des-phe(8)-)
Recent Studies (post-2010)
(angiotensin ii, des-phe(8)-)
Studies
(guanosine triphosphate)
Trials
(guanosine triphosphate)
Recent Studies (post-2010) (guanosine triphosphate)
1,5332199514,728252,115

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abi-Abib, R; Cardozo, FP; Caruso-Neves, C; De Souza, AM; Fernandes, MS; Fossari, RN; Lopes, AG; Miguel, NC; Pizzino, CP; Santos, DP1

Other Studies

1 other study(ies) available for angiotensin ii, des-phe(8)- and guanosine triphosphate

ArticleYear
Angiotensin II and angiotensin-(1-7) inhibit the inner cortex Na+ -ATPase activity through AT2 receptor.
    Regulatory peptides, 2004, Aug-15, Volume: 120, Issue:1-3

    Topics: Adjuvants, Immunologic; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Cholera Toxin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; GTP-Binding Proteins; Guanosine Diphosphate; Guanosine Triphosphate; Imidazoles; Kidney Cortex; Losartan; Peptide Fragments; Pertussis Toxin; Pyridines; Receptor, Angiotensin, Type 2; Sodium-Potassium-Exchanging ATPase; Swine; Vasoconstrictor Agents

2004